Press Review… Winter Press Review 2024 – Seminars in Arthritis and Rheumatology 10 Jan 2024 August 2023 to November 2023 Authors: Dalifer Freites Nuñez and Alejandro Gómez Gómez Seminars in Arthritis and Rheumatology Non-pharmacological interventions in Fibromyalgia Bidonde et al. (doi.org/10.1016/j.semarthrit.2023.152248) aimed to examine the efficacy and…
Press Review… Winter Press Review 2024 – Rheumatology (Oxford) 10 Jan 2024 August 2023 to November 2023 Authors: Dalifer Freites Nuñez and Alejandro Gómez Gómez Rheumatology (Oxford) Anifrolumab and SLE Yusuke Miyazaki et al. (doi.org/10.1093/rheumatology/kead568) determined the safety and efficacy of anifrolumab in patients…
Arthritis Research and Therapy… Winter Press Review 2024 – Arthritis Research & Therapy 10 Jan 2024 August 2023 to November 2023 Authors: Aleksandra Opinc-Rosiak and Giacomo Cafaro Arthritis Research & Therapy HFA-PEFF score in idiopathic inflammatory myopathies Shi et al. (doi.org/10.1186/s13075-023-03131-6) investigated the utility of the HFA-PEFF score in detecting HFpEF in patients…
Press Review… Winter Press Review 2024 – The Lancet Rheumatology 10 Jan 2024 August 2023 to November 2023 Authors: Aleksandra Opinc-Rosiak and Giacomo Cafaro The Lancet Rheumatology Colchicine vs Prednisone for calcium pyrophosphate arthritis Pascart et al (doi.org/10.1016/S2665-9913(23)00165-0) compared the efficacy and safety of…
ACR Highlights… ACR Convergence Highlights 2023 – Basic Research I: Genetics, cartilage/synovium, osteoimmunology, animal models 9 Dec 20239 Dec 2023 Author: Rami Bechara Hou et al. (0733) utilised CRISPR/Cas9 technology to identify cell type-specific functional variants that regulate the Type I interferon pathway in lupus. Notably, they discovered the negative regulatory effect…
ACR Highlights… ACR Convergence Highlights 2023 – Basic Research II: Immunity, Immunology 9 Dec 20239 Dec 2023 Author: Latika Gupta Ghossan et al. (0732) established that while B cell depletion is associated with a better response to RTX at the start of treatment, the persistence of complete B cell depletion is not…
ACR Highlights… ACR Convergence Highlights 2023 – Rheumatoid Arthritis: Clinical (therapeutic) 9 Dec 20239 Dec 2023 Author: Victoria Konzett Cope et al. (0835) investigated the efficacy of T-cell co-stimulation with Abatacept on prevention of disease onset in an autoantibody-positive population with arthralgia at risk of developing RA,…
ACR Highlights… ACR Convergence Highlights 2023 – Spondyloarthritis I: Clinical (non-therapeutic) 9 Dec 20239 Dec 2023 Author: Olivier Fakih Michel et al. (2222) compared patients with a SpA + IBD codiagnosis versus those with only one diagnosis in a retrospective monocentric study. 62 patients with a…
ACR Highlights… ACR Convergence Highlights 2023 – Spondyloarthritis II: Clinical (therapeutic) 9 Dec 20239 Dec 2023 Author: Bayram Farisogullari Kivitz et al. (0776) investigated the long-term efficacy, safety, and tolerability of intravenous (IV) secukinumab (SEC) in patients with active PsA through 52 weeks in a randomised,…
ACR Highlights… ACR Convergence Highlights 2023 – SLE and APS 9 Dec 20239 Dec 2023 Author: Anastasia Madenidou Schett et al. (0607) followed up 8 SLE patients who received treatment with CD19 CAR T cell therapy. Five patients had a follow-up of more than one year…